Hyperion Therapeutics

About:

Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.

Website: http://www.hyperiontx.com

Top Investors: New Enterprise Associates, Sofinnova Investments, EQT Life Sciences, Highland Capital Partners, Bay City Capital

Description:

Hyperion is a biotech company developing therapies to address "orphan or underserved patient populations." They are located in South San Francisco, CA.

Total Funding Amount:

$222M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2006-01-01

Contact Email:

kim.gray(AT)hyperiontx.com

Founders:

Mark Blumling

Number of Employees:

501-1000

Last Funding Date:

2013-03-08

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai